SNCA and Parkinson disease: These findings suggest that inhibition of complex I activity contributes to dopamine loss and α-synuclein pathology and promotes nonmotor symptoms of PD, but it is not sufficient to cause neurodegeneration during aging, suggesting the existence of additional susceptibility factors.